Abstract
SILAC technology in combination with high-resolution mass spectrometry (MS) can be successfully used to measure phosphoproteomes in vivo. Here, Zanivan, Mann, and colleagues have applied SILAC-based MS to investigate phosphoproteomic changes during skin carcinogenesis, using the DMBA/TPA two-stage mouse model. Using this approach, the authors have revealed the phosphoproteomic dynamics that accompany skin cancer progression and predict specific kinase activities associated with tumor malignancy.
Original language | English |
---|---|
Journal | Cell Reports |
Volume | 3 |
Issue number | 2 |
Pages (from-to) | 552-566 |
DOIs | |
Publication status | Published - 2013 |